INSERM U1183 "Cellules souches, plasticité cellulaire, médecine régénératrice et immunothérapies"
  • Accueil
  • Equipes
    • Equipe 1 >
      • Daniele Noel
      • Farida Djouad
      • Christian Jorgensen
      • Martine Daujat
      • Carole Crozet
    • Equipe 2 >
      • Jean-Marc Lemaitre
      • John De Vos
      • Therese Commes
    • Equipe 3 >
      • Isabelle Touitou-David Geneviève
      • Pascale Louis-Plence
      • Florence Apparailly
      • Mireia Pelegrin
    • Equipe 4 >
      • Martin Villalba
      • Javier Hernandez
  • Laboratoires hospitaliers - Plateformes
  • Unité clinique
  • Enseignement
  • Actualités
  • Acces & Contact
  • Annuaire

Laboratory of Biochemistry – Clinical Proteomic


The clinico-biological research focus of the team is in the field of neurodegenerative disorders and in particular in Alzheimer's disease (AD) that affects more than 800,000 people in France and represents a major public health problem. The team is at the forefront of biological diagnosis of this pathology by demonstrating the interest of biomarkers of cerebrospinal fluid (CSF) in routine and by proposing new recommendations for their use.

This activity is supported by the establishment of a BioBank with more than 1500 patients and the research programs of novel biomarkers (including a patent CHRU No. EP13305614.3 filed on 05/15/13). The LBPC is also a NFS 96-900 certified component of the Biological Resource Centre (CRB) of the CHRU de Montpellier. The team has a strong expertise in clinical Proteomics internationally recognized and supported with access to two analyzers of last generation for quantitative, differential (MRM and HRMS) mass spectrometry analyses.

Thanks to access to clinical samples this expertise has enabled the team to propose innovative approaches in the field of clinical biology that are the basis of many publications and coordination or participation in clinical research programs as follows: 
  • PHRC national PROMARA: Use of targeted quantitative proteomics and metabolic labeling with stable isotopes for the diagnosis and the investigation of neurological disorders and in particular Alzheimer Disease.
  • BIOMARKAPD FP7 Joint Programming Neurodegenerative Disease (JPND): “Biomarkers for Alzheimer’s disease and Parkinson’s disease”.
  • PSTIC/PRME HEPCIDANE: Multi-centric medico-economical evaluation of the interest of hepcidin in the management of anaemia in critical care. 
  • AOI CHRU SalivAlz : Follow-up of Alzheimer biomarkers in the saliva of dementia patients.
  • AOI CHRU DBSage : Use of the Dried Blood Spot for the follow-up of blood clinical parameters of the old people.
  • PHRC national BALTAZAR : Biomarker of AmyLoïd pepTide and Alzheimer disease Risk.
  • AOI CHRU Epi : Inflammatory biomarer blood profile in frontal lobe epilepty.
  • ANR BUVAMASS : Use of dried blood spot for clinical mass spectrometry analysis.
Photo
Photo
Figure 1
Figure 2
Photo
Figure 3
Photo
Figure 4

Bibliography

 - Lehmann et al. (2015) Clin Chem Lab Med doi: 10.1515/cclm-2014-1232. [IF=3.01] [SIGAPS=18]

- Dumurgier J… & Lehmann S (2015). Alzheimers Res Ther. In press [IF=3,5] [SIGAPS=24]

- Lehmann et al (2014) Alzheimers Dement. doi: 10.1016/j.jalz.2014.09.003 [IF= 17.47] [SIGAPS=32]

- Lehmann et al. (2014) PLoS ONE 9, no. 2: e88797 [IF=4,35] [SIGAPS=18]

- Lehmann et al (2014) Alzheimers Res Ther. 2014 Jun 26;6(3):38 [IF=3,5] [SIGAPS=24]

- Dauvilliers, Lehmann et al. (2014) Front Aging Neurosci. doi: 10.3389 [IF=2,84] [SIGAPS=18]

- Gabelle et al (2014) Alzheimers Dement. doi: 10.1016/j.jalz.2014.04.515  [IF= 17.47] [SIGAPS=32]    

- Lehmann et al (2013) Alzheimers Dement. Epub 2013/11/26 [IF= 14.48] [SIGAPS=32]

- Dumurgier et al (2013) Neurobiol Dis. 2013 Feb 13. doi:pii: S0969-9961. [IF=5.62] [SIGAPS=24]

- Lehmann et al. (2013) Clin Chem Lab Med 51, 1897-909.[IF=3.01] [SIGAPS=18]

- Delaby C. & Lehmann (2013) Clin Chem Lab Med 52:649-55 [IF=3.01] [SIGAPS=18]

- Un brevet intitulé « Method For In Vitro Diagnosis Of A Neurological Disorder » a été déposé le 15 mai 2013 à l'Office Européen des Brevets sous le n° EP13305614.3, Brevet français du CHRU de Montpellier/Université Montpellier 1.

Manager
Photo
Sylvain LEHMANN

Details
tel: +33 (0)4 67 33 71 23    
email: s-lehmann@chu-montpellier.fr

Websites:

http://www.chu-montpellier.fr/fr/coen/

http://www.chu-montpellier.fr/fr/chercheurs/plateformes/les-plateformes-recherche/collections-biologiques/    

Group
LEHMANN Sylvain (PU-PH UM/CHU)
DELABY Constance (MCU/UM)
HIRTZ Christophe (MCU/UM)
BROS Pauline (Doctorante/UM)
VIALARET Jérome (IE/contractuel)
TIERS Laurent (IE/CHU)
MALESKA Aleksandra (IE/CHU)
MOULINIER Amandine (Tech/CHU)
GIRARD Marine (TRC/CHU)

Keywords
Neurodegenerative diseases
Biomarkers
Clinical Biology
Proteomics

Technical skills
Biochemistry/proteomic:
  • Western Blot
  • gels-2D
  • ELISA simplex/multiplexe (Technologie Mesoscale Discovery)
  • LC-MS/MS
  • SRM/MRM
  • HRMS

Version française
Photo

Accueil

Equipes

Plateformes

Accès & Contact

Annuaire